ClinicalTrials.Veeva

Menu

Retrospective Analysis of Patients Implanted With 2 Levels of Prodisc® C Vivo Devices

C

Centinel Spine

Status

Invitation-only

Conditions

Symptomatic Cervical Disc Disease
Degenerative Disc Disease
Cervical Spine Degenerative Disc Disease
Cervical Spine Degenerative Disease

Treatments

Device: Prodisc C Vivo

Study type

Observational

Funder types

Industry

Identifiers

NCT07370493
VAL-P-0190

Details and patient eligibility

About

The objective of the study is to evaluate the safety and post-operative performance profile of the prodisc® C Vivo after implantation in comparison to the relevant clinical literature.

Full description

The primary objective of the study is to evaluate (estimate) the post-operative performance of prodisc® C Vivo overall, after implantation. Post-operative device performance will be estimated using Patient Reported Outcomes (PROs) and radiographic data derived from the patient's surgical charts and medical history.

The secondary objectives of this study are to assess:

  • patients with no secondary surgical interventions (SSIs), i.e. revision, removal, re-operation, supplemental fixation at the index level(s)
  • the rates of ADEs inclusive of intraoperative and post-operative complications
  • Patient Reported Outcomes (PROs)
  • Outcome self-assessment of Health Survey (SF 12 or 36 as available)

Enrollment

200 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • In order for a patient's data to be included in this study, he/she has to meet the indications and not possess any of the specific or general contraindications listed in the Instructions For Use (IFU).
  • They must provide written informed consent with appropriate documentation noted in source documentation (prospective cohort only).

Exclusion criteria

-There are no additional exclusion criteria.

Trial design

200 participants in 2 patient groups

Retrospective chart review
Description:
Retrospective chart review of patients treated with prodisc® C Vivo at 2 contiguous levels.
Treatment:
Device: Prodisc C Vivo
Prospective follow-up
Description:
Prospective follow-up of patients treated with prodisc® C Vivo at 2 contiguous levels.
Treatment:
Device: Prodisc C Vivo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems